BB
ITCI
BB Biotech’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $26.8M | Hold |
2,200,000
| – | – | 0.67% | 29 |
|
|
2018
Q4 | $25.1M | Hold |
2,200,000
| – | – | 0.8% | 28 |
|
|
2018
Q3 | $47.7M | Hold |
2,200,000
| – | – | 1.26% | 25 |
|
|
2018
Q2 | $38.9M | Hold |
2,200,000
| – | – | 1.12% | 22 |
|
|
2018
Q1 | $46.3M | Hold |
2,200,000
| – | – | 1.28% | 20 |
|
|
2017
Q4 | $31.9M | Hold |
2,200,000
| – | – | 0.9% | 20 |
|
|
2017
Q3 | $34.7M | Buy |
2,200,000
+50,000
| +2% | +$789K | 0.96% | 20 |
|
|
2017
Q2 | $26.7M | Buy |
2,150,000
+225,000
| +12% | +$2.79M | 0.82% | 22 |
|
|
2017
Q1 | $31.3M | Buy |
1,925,000
+350,000
| +22% | +$5.69M | 1.02% | 21 |
|
|
2016
Q4 | $23.8M | Buy |
1,575,000
+225,000
| +17% | +$3.4M | 0.88% | 21 |
|
|
2016
Q3 | $20.6M | Buy |
1,350,000
+650,000
| +93% | +$9.91M | 0.72% | 22 |
|
|
2016
Q2 | $27.2M | Buy |
+700,000
| New | +$27.2M | 1.07% | 21 |
|